CK Life Sciences, the biotech arm of Hong Kong billionaire Li Ka-shing, has agreed to merge a Canadian drug development unit, WEX Pharmaceuticals, with Nasdaq-listed Virios Therapeutics. CK Life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback